This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nicosia, R. F. Articles by Bonanno, E. Search for Related Content PubMed PubMed Citation Articles by Nicosia, R. F. Articles by Bonanno, E.

American Journal of Pathology, Vol 138, 829-833, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide

RF Nicosia and E Bonanno
Department of Pathology, Medical College of Pennsylvania, Philadelphia 19129.

This study was designed to evaluate the effect of the synthetic peptide Gly-Arg-Gly-Asp-Ser (GRGDS) on angiogenesis in serum-free collagen gel culture of rat aorta. The GRGDS peptide contains the amino acid sequence Arg-Gly-Asp (RGD), which has been implicated as a recognition site in interactions between extracellular matrix (ECM) molecules and cell membrane receptors. RGD-containing synthetic peptides are known to inhibit attachment of endothelial cells to substrates, but their effect on angiogenesis has not been fully characterized. Aortic explants embedded in collagen gel in the absence of GRGDS generated branching microvessels through a process of endothelial migration and proliferation. Addition of GRGDS to the culture medium caused a marked inhibition of angiogenesis. In contrast, GRGES, a control peptide lacking the RGD sequence, failed to inhibit angiogenesis. The inhibitory effect of GRGDS was nontoxic and reversible. The angiogenic activity of aortic explants previously inhibited with GRGDS could be restored by incubating the cultures in GRGDS-free medium. These findings suggest that angiogenesis is an anchorage-dependent process that can be inhibited by interfering with the attachment of endothelial cells to the ECM. It also indicates that synthetic peptides can be used as probes to study the mechanisms by which the ECM regulates angiogenesis.

This article has been cited by other articles:

				T. J. MacDonald, C. F. Stewart, M. Kocak, S. Goldman, R. G. Ellenbogen, P. Phillips, D. Lafond, T. Y. Poussaint, M. W. Kieran, J. M. Boyett, et al. Phase I Clinical Trial of Cilengitide in Children With Refractory Brain Tumors: Pediatric Brain Tumor Consortium Study PBTC-012 J. Clin. Oncol., February 20, 2008; 26(6): 919 - 924. [Abstract] [Full Text] [PDF]

				V. Pedchenko, R. Zent, and B. G. Hudson {alpha}v{beta}3 and {alpha}v{beta}5 Integrins Bind Both the Proximal RGD Site and Non-RGD Motifs within Noncollagenous (NC1) Domain of the {alpha}3 Chain of Type IV Collagen: IMPLICATION FOR THE MECHANISM OF ENDOTHELIAL CELL ADHESION J. Biol. Chem., January 23, 2004; 279(4): 2772 - 2780. [Abstract] [Full Text] [PDF]

				S. Kakolyris, A. Giatromanolaki, M. Koukourakis, I. M. Leigh, V. Georgoulias, P. Kanavaros, E. Sivridis, K. C. Gatter, and A. L. Harris Assessment of Vascular Maturation in Non-Small Cell Lung Cancer Using a Novel Basement Membrane Component, LH39: Correlation with p53 and Angiogenic Factor Expression Cancer Res., November 1, 1999; 59(21): 5602 - 5607. [Abstract] [Full Text] [PDF]

				G Collo and M. Pepper Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro J. Cell Sci., January 2, 1999; 112(4): 569 - 578. [Abstract] [PDF]

				S. M. Dallabrida, M. A. De Sousa, and D. H. Farrell Expression of Antisense to Integrin Subunit beta 3 Inhibits Microvascular Endothelial Cell Capillary Tube Formation in Fibrin J. Biol. Chem., October 6, 2000; 275(41): 32281 - 32288. [Abstract] [Full Text] [PDF]